Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CATEQUENTINIB: 324 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
324
Total FAERS Reports
44 (13.6%)
Deaths Reported
115
Hospitalizations
324
As Primary/Secondary Suspect
21
Life-Threatening
6
Disabilities

First Report: 20140101 · Latest Report: 20250901

What Are the Most Common CATEQUENTINIB Side Effects?

#1 Most Reported
Myelosuppression
84 reports (25.9%)
#2 Most Reported
Off label use
37 reports (11.4%)
#3 Most Reported
Diarrhoea
33 reports (10.2%)

All CATEQUENTINIB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myelosuppression 84 25.9% 5 35
Off label use 37 11.4% 14 6
Diarrhoea 33 10.2% 4 4
Hypertension 26 8.0% 1 2
Nausea 26 8.0% 3 1
Vomiting 26 8.0% 2 1
Rash 25 7.7% 3 3
Thrombocytopenia 24 7.4% 2 0
Fatigue 23 7.1% 2 0
Anaemia 22 6.8% 3 0
Decreased appetite 22 6.8% 2 3
Leukopenia 21 6.5% 1 0
Disease progression 20 6.2% 3 3
Hypothyroidism 20 6.2% 2 3
Neutropenia 19 5.9% 2 1
Hepatic function abnormal 18 5.6% 3 5
White blood cell count decreased 18 5.6% 2 6
Palmar-plantar erythrodysaesthesia syndrome 17 5.3% 2 2
Platelet count decreased 17 5.3% 2 10
Product use in unapproved indication 16 4.9% 3 8

Who Reports CATEQUENTINIB Side Effects? Age & Gender Data

Gender: 38.7% female, 61.3% male. Average age: 57.2 years. Most reports from: CN. View detailed demographics →

Is CATEQUENTINIB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 1 1 0
2018 3 1 0
2019 8 4 3
2020 7 0 3
2021 19 1 10
2022 31 5 22
2023 26 3 12
2024 56 0 35
2025 17 0 8

View full timeline →

What Is CATEQUENTINIB Used For?

IndicationReports
Lung neoplasm malignant 41
Non-small cell lung cancer 24
Lung adenocarcinoma 20
Small cell lung cancer extensive stage 19
Small cell lung cancer 12
Oesophageal carcinoma 10
Breast cancer 8
Breast cancer metastatic 7
Colorectal cancer metastatic 7
Lung adenocarcinoma stage iv 7

CATEQUENTINIB vs Alternatives: Which Is Safer?

CATEQUENTINIB vs CC-4047 CATEQUENTINIB vs CEDAZURIDINE\DECITABINE CATEQUENTINIB vs CEDIRANIB CATEQUENTINIB vs CEFACLOR CATEQUENTINIB vs CEFADROXIL CATEQUENTINIB vs CEFAZOLIN CATEQUENTINIB vs CEFDINIR CATEQUENTINIB vs CEFEPIME CATEQUENTINIB vs CEFEPIME\CEFEPIME CATEQUENTINIB vs CEFIDEROCOL

Official FDA Label for CATEQUENTINIB

Official prescribing information from the FDA-approved drug label.